Form D · Biotechnology

Allelica, Inc.

Rome, L6 · CIK 0001857831

Offering snapshot reported Feb 10, 2022 · SEC filing

Reported sold
$1.68M
Offering amount: $1.75M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 5, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$840K$1.68MApr 20, 2021: $1,655,000.00Apr 20, 2021Feb 10, 2022: $1,680,000.00Feb 10, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,655,000 → $1,680,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 10, 2022Amendment$1,680,000$25,000vs Apr 20, 20218SEC filing
Apr 20, 2021Initial$1,655,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-396425

Source: Form D, filed Feb 10, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Giordano Botta Director, Executive
Paolo Di Domenico Director
Gary Peat Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Largo Della Fontanella Di Borghese 19
Rome, L6, 00186